VH 4527079
Latest Information Update: 16 Jan 2025
Price :
$50 *
At a glance
- Originator ViiV Healthcare
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I HIV infections
Most Recent Events
- 02 Oct 2024 Phase-I clinical trials in HIV infections in USA (Parenteral) before October 2024 (NCT06652958)